[go: up one dir, main page]

NO20092341L - Substituerte piperidiner inneholdende et heteroarylamid eller en heteroarylfenyl gruppe - Google Patents

Substituerte piperidiner inneholdende et heteroarylamid eller en heteroarylfenyl gruppe

Info

Publication number
NO20092341L
NO20092341L NO20092341A NO20092341A NO20092341L NO 20092341 L NO20092341 L NO 20092341L NO 20092341 A NO20092341 A NO 20092341A NO 20092341 A NO20092341 A NO 20092341A NO 20092341 L NO20092341 L NO 20092341L
Authority
NO
Norway
Prior art keywords
group
heteroarylamide
substituted piperidines
ring
heteroarylphenyl group
Prior art date
Application number
NO20092341A
Other languages
English (en)
Inventor
Richard William Arthur Luke
Marinus Leendert Verdonk
Steven John Woodhead
Hannah Fiona Sore
David Winter Walker
Christopher Hamlett
Ian Collins
Kwai Ming Cheung
John Caldwell
Tatiana Faria Da Fonseca Mchardy
Zbigniew Stanley Matusiak
Gregory Richard Carr
Jeffrey James Morris
Original Assignee
Cancer Res Inst Royal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0625682A external-priority patent/GB0625682D0/en
Application filed by Cancer Res Inst Royal filed Critical Cancer Res Inst Royal
Publication of NO20092341L publication Critical patent/NO20092341L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen tilveiebringer forbindelser med formel (I) som er PKA- og PKB-kinase-hemmende forbindelser med formel (I): eller salter, solvater, tautomerer eller N-oksider derav, hvor. (1) GP er en gruppe GP1:. (2) GP er en gruppe GP2:. hvor HET er en monocyklisk eller bicyklisk, heterocyklisk gruppe som inneholder opptil 4 ring-heteroatomer; ringen V er en monocyklisk eller bicyklisk heteroarylgruppe med 5 til 10 ledd i ringen; og,,,, R, Q, Ga, x, w og fer som definert i kravene.
NO20092341A 2006-12-21 2009-06-18 Substituerte piperidiner inneholdende et heteroarylamid eller en heteroarylfenyl gruppe NO20092341L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87135506P 2006-12-21 2006-12-21
GB0625682A GB0625682D0 (en) 2006-12-21 2006-12-21 Pharmaceutical compounds
US98263607P 2007-10-25 2007-10-25
US98615007P 2007-11-07 2007-11-07
PCT/GB2007/050777 WO2008075110A1 (en) 2006-12-21 2007-12-20 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety

Publications (1)

Publication Number Publication Date
NO20092341L true NO20092341L (no) 2009-07-21

Family

ID=39301245

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092341A NO20092341L (no) 2006-12-21 2009-06-18 Substituerte piperidiner inneholdende et heteroarylamid eller en heteroarylfenyl gruppe

Country Status (15)

Country Link
US (1) US20100120798A1 (no)
EP (1) EP2125820A1 (no)
JP (1) JP2010513453A (no)
KR (1) KR20090104030A (no)
AR (1) AR064415A1 (no)
AU (1) AU2007335969A1 (no)
BR (1) BRPI0721124A2 (no)
CA (1) CA2672841A1 (no)
EC (1) ECSP099446A (no)
MX (1) MX2009006650A (no)
NO (1) NO20092341L (no)
PE (1) PE20081680A1 (no)
TW (1) TW200833694A (no)
UY (1) UY30823A1 (no)
WO (1) WO2008075110A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY179032A (en) 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
EP2043655A2 (en) 2006-04-25 2009-04-08 Astex Therapeutics Limited Purine and deazapurine derivatives as pharmaceutical compounds
JP4705695B2 (ja) 2007-10-11 2011-06-22 アストラゼネカ アクチボラグ プロテインキナーゼｂ阻害剤としてのピロロ［２，３−ｄ］ピリミジン誘導体
EA019488B1 (ru) * 2008-04-21 2014-04-30 Лексикон Фармасьютикалз, Инк. Ингибиторы limk2 и способы их применения
US9045485B2 (en) 2010-12-16 2015-06-02 Convergence Pharmaceuticals Limited ASK 1 inhibiting pyrrolopyrimidine derivatives
JP6080837B2 (ja) 2011-04-01 2017-02-15 アストラゼネカ アクチボラグ 療法的治療
CN103814030A (zh) * 2011-09-22 2014-05-21 辉瑞大药厂 吡咯并嘧啶及嘌呤衍生物
KR102035361B1 (ko) 2011-11-30 2019-11-08 아스트라제네카 아베 암의 병용 치료
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms
CN104119342A (zh) * 2013-04-25 2014-10-29 苏州科捷生物医药有限公司 一种制备高纯度4-氯-5-甲基-7H-吡咯[2,3-d]嘧啶的方法
PT3980417T (pt) 2019-06-10 2023-12-28 Lupin Ltd Inibidores de prmt5

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5213229B2 (ja) * 2004-04-23 2013-06-19 エグゼリクシス， インコーポレイテッド キナーゼ調節因子および使用方法
MY179032A (en) * 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
US7994172B2 (en) * 2004-12-28 2011-08-09 Exelixis, Inc. [1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
EP2013206A1 (en) * 2006-04-25 2009-01-14 Astex Therapeutics Limited Pharmaceutical compounds
EP2029592A1 (en) * 2006-04-25 2009-03-04 Astex Therapeutics Limited Pharmaceutical compounds
WO2007125310A2 (en) * 2006-04-25 2007-11-08 Astex Therapeutics Limited Pharmaceutical combinations of pk inhibitors and other active agents

Also Published As

Publication number Publication date
WO2008075110A1 (en) 2008-06-26
PE20081680A1 (es) 2008-12-18
AU2007335969A1 (en) 2008-06-26
CA2672841A1 (en) 2008-06-26
BRPI0721124A2 (pt) 2014-03-04
ECSP099446A (es) 2009-09-29
KR20090104030A (ko) 2009-10-05
JP2010513453A (ja) 2010-04-30
EP2125820A1 (en) 2009-12-02
TW200833694A (en) 2008-08-16
AR064415A1 (es) 2009-04-01
UY30823A1 (es) 2008-07-31
US20100120798A1 (en) 2010-05-13
MX2009006650A (es) 2009-08-20

Similar Documents

Publication Publication Date Title
NO20092341L (no) Substituerte piperidiner inneholdende et heteroarylamid eller en heteroarylfenyl gruppe
NO20071073L (no) Heterocykel-substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer
NO341631B1 (no) Hydroksybenzamidderivater og deres anvendelse, fremgangsmåte for fremstilling og farmasøytiske sammensetninger
NO20082116L (no) Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse
NO20083582L (no) Pyridin-2-karboksamide derivater
NO20070731L (no) Heterocykliske forbindelser.
NO20073663L (no) Tiazol-4-karboksamid-derivater som mGluR5 antagonister
NO20082388L (no) Heteroaryl substituerte piperidinderivater som L-CPT1 inhibitorer
NO20073859L (no) Pyrrolopyrazoler, potente kinaseinhibitorer
NO20084583L (no) Makrosykliske kinase-inhibitorer
NO20091590L (no) Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
NO20071593L (no) Pyrimidinderivater
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
NO20071504L (no) Pyrimidinderivanter.
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer
NO20073956L (no) Pyrazolderivater for inhibering av CDK og GSK
NO20072963L (no) 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere
TW200732306A (en) Pyrimidine derivatives
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
NO20083909L (no) Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere
NO20085107L (no) Spirosykliske nitriler som proteaseinhibitorer
NO20082121L (no) Imidazopyridinderivater som A2B-adenosinreseptorantagonister
NO20092286L (no) Nitrogenhaldige heterosykliske forbindelser og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application